Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021350

CHIEF EXECUTIVE OFFICER sold 40,000 shares at $55.25 ($2,210,040)

  • CHIEF EXECUTIVE OFFICER acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-08-07 Option exercise 10b5-1 +40,000 $2.94 $117,440 178,641 D
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-08-07 Sale 10b5-1 −40,000 $55.25 $2,210,040 138,641 D
Derivatives
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-08-07 Option exercise · Employee Stock Option (right to buy) 10b5-1 −40,000 198,487 D
Open-market sales · 40,000 sh · avg $55.25 · $2,210,040
Loading xslF345X05/form4-08082025_080828.xml…